Biotechnologieaktien – KI-Analyse & Ranglisten
Diese Seite wurde per KI maschinell aus dem englischen Original übersetzt; die englische Fassung ist maßgeblich. Englische Fassung lesen
Kurzantwort
Durchsuchen Sie alle Biotechnologieaktien mit KI-gestützter Analyse, MoonshotScores und Kurszielen.
Durchsuchen Sie alle Biotechnologieaktien mit KI-gestützter Analyse, MoonshotScores und Kurszielen.
Verwandte Aktien in Biotechnologie
| Unternehmen | Kurs | Änderung | Marktkapitalisierung | MoonshotScore |
|---|---|---|---|---|
| EXEL Exelixis, Inc. | $58.85 | +0.79% | $14.8B | — |
| HRMY Harmony Biosciences Holdings, Inc. | $39.92 | +0.71% | $2.31B | — |
| INCY Incyte Corporation | $113.81 | -1.29% | $23.1B | — |
| KRYS Krystal Biotech, Inc. | $322.28 | -0.93% | $9.50B | — |
| ARGX argenx SE | $919.21 | -1.79% | $57.2B | — |
| AUPH Aurinia Pharmaceuticals Inc. | $15.72 | -0.69% | $2.02B | — |
| ETON Eton Pharmaceuticals, Inc. | $55.62 | +0.47% | $1.52B | — |
| HALO Halozyme Therapeutics, Inc. | $108.53 | -1.22% | $12.9B | — |
| UTHR United Therapeutics Corporation | $536.40 | -0.98% | $22.8B | — |
| VRTX Vertex Pharmaceuticals Incorporated | $504.73 | -0.40% | $128B | — |
| LGND Ligand Pharmaceuticals Incorporated | $306.77 | +1.26% | $6.15B | — |
| VCYT Veracyte, Inc. | $46.52 | +1.55% | $3.71B | — |
| INVA Innoviva, Inc. | $20.50 | -0.24% | $1.51B | — |
| TBPH Theravance Biopharma, Inc. | $17.03 | — | $883M | — |
| ADMA ADMA Biologics, Inc. | $10.11 | +4.01% | $2.34B | — |
| CRMD CorMedix Inc. | $7.27 | +1.17% | $571M | — |
| REGN Regeneron Pharmaceuticals, Inc. | $726.94 | -1.12% | $74.9B | — |
| RIGL Rigel Pharmaceuticals, Inc. | $47.79 | +1.36% | $884M | — |
| TECH Bio-Techne Corporation | $72.58 | +0.25% | $11.4B | — |
| LQDA Liquidia Corporation | $27.11 | -5.32% | $2.41B | — |
| NBIX Neurocrine Biosciences, Inc. | $144.21 | +0.72% | $14.5B | — |
| VCEL Vericel Corporation | $41.07 | +2.29% | $2.10B | — |
| CORT Corcept Therapeutics Incorporated | $121.38 | +4.43% | $13.1B | — |
| NVO Novo Nordisk A/S | $37.32 | -0.21% | $166B | — |
| ZVRA Zevra Therapeutics, Inc. | $10.70 | +7.11% | $633M | — |
| ALNY Alnylam Pharmaceuticals, Inc. | $219.72 | -4.96% | $29.4B | — |
| CAI Caris Life Sciences, Inc. | $30.20 | +6.70% | $8.54B | — |
| ARQT Arcutis Biotherapeutics, Inc. | $25.15 | -0.04% | $3.15B | — |
| ASND Ascendis Pharma A/S | $228.03 | +0.07% | $14.2B | — |
| MDXG MiMedx Group, Inc. | $4.59 | -1.08% | $669M | — |
| ABUS Arbutus Biopharma Corporation | $4.67 | +4.94% | $923M | — |
| RLYB Rallybio Corporation | $16.90 | -1.05% | $89.7M | — |
| ANAB AnaptysBio, Inc. | $49.20 | +1.38% | $1.46B | — |
| ICCC ImmuCell Corporation | $9.75 | — | $88.2M | — |
| PHAR Pharming Group N.V. | $9.80 | +0.51% | $694M | — |
| ACAD ACADIA Pharmaceuticals Inc. | $20.11 | +0.80% | $3.44B | — |
| ORMP Oramed Pharmaceuticals Inc. | $4.55 | +1.34% | $186M | — |
| PTGX Protagonist Therapeutics, Inc. | $141.19 | +0.81% | $9.08B | — |
| ELVN Enliven Therapeutics, Inc. | $45.47 | -3.19% | $3.25B | — |
| PLX Protalix BioTherapeutics, Inc. | $2.71 | — | $218M | — |
| RPRX Royalty Pharma plc | $56.66 | -0.87% | $25.1B | — |
| MBX MBX Biosciences | $58.73 | +0.38% | $2.80B | — |
| BLTE Belite Bio, Inc. | $159.73 | +0.11% | $6.40B | — |
| LBRX LB Pharmaceuticals Inc | $34.62 | -6.41% | $993M | — |
| CLYM Climb Bio, Inc. | $11.05 | +1.01% | $633M | — |
| NAGE Niagen Bioscience Inc | $2.68 | -3.94% | $213M | — |
| ORKA Oruka Therapeutics, Inc. | $84.38 | -0.17% | $5.09B | — |
| ANTX AN2 Therapeutics, Inc. | $5.61 | -1.75% | $202M | — |
| QTTB Q32 Bio Inc. | $8.37 | +1.70% | $249M | — |
| AMLX Amylyx Pharmaceuticals, Inc. | $27.48 | -1.12% | $3.06B | — |
KI-Score von Stock Expert AI · Kursdaten: FMP / Yahoo Finance